A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness.
A new $16,000 postpartum depression drug is here. How will insurers handle it?
- Post author:
- Post published:March 12, 2024
- Post category:uncategorized